Research programme: activated prodrugs - SupratekAlternative Names: SP-1008A
Latest Information Update: 28 Nov 2007
At a glance
- Originator Supratek Pharma
- Mechanism of Action Nucleoside reverse transcriptase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 19 Aug 2004 Preclinical trials in HIV infections treatment in USA (unspecified route)